tagging recent news
Healthcare
PharmStar Pharmaceuticals Names Dr. Antonio Hernandez to Medical Advisory Board
August 10, 2011
by MARKET WIRE
in Healthcare
WILSON, NC -- (Marketwire) -- 08/10/11 -- PharmStar Pharmaceuticals, Inc. (PINKSHEETS: PHAR) (the "Company") announced today that Dr. Antonio Hernandez has accepted an invitation to join the Company's Medical Advisory Board (MAB).The Medical Advisory Board will be instrumental in overseeing the protocols established for the Company's 3rd party claims testing, and develop testing protocols for future product offerings by the Company. While Aquaprin needs no further development and testing as an OTC product, the Board will establish protocols for developing a prescription strength ver [...]
Metrasens Spotlights New Ferroguard Screener at AHRA Congress
August 10, 2011
by MARKET WIRE
in Healthcare
MALVERN, UNITED KINGDOM -- (Marketwire) -- 08/10/11 -- Metrasens, world leader in ferromagnetic detection (FMD) technology, announces today that its new Ferroguard Screener system will be the focus of the company's presence at the important Association for Medical Imaging Management (AHRA) congress next week in Grapevine, Tx. The new product was launched in May 2011, is already in use in MRI departments in Europe and this will be its first showing at a US congress.Ferroguard Screener is a unique "on-demand" ferromagnetic screening system that provides instant whole-body safety scre [...]
Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer
August 10, 2011
by MARKET WIRE
in Healthcare
PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 08/10/11 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX) today announced that the European Patent Office has issued patent number 1507554, entitled, "Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases," covering the use of oral human lactoferrins, including talactoferrin, to treat cancer. It also covers the use of talactoferrin in combination with other therapies, including chemotherapy, immunotherapy, radiation therapy and other treatments. The patent has a t [...]
